Recurrent vaginal shedding of herpes simplex type 2 virus in the mouse and effects of antiviral therapy
Authors:
- David I. BernsteinDBDavid I. Bernstein
- Fernando J. BravoFBFernando J. Bravo
- Julie EarwoodJEJulie Earwood
- Nancy SawtellNSNancy Sawtell
- Rhonda D. CardinRCRhonda D. Cardin
- 1 May 2010
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 86 (2) , 188-195
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigsVaccine, 2010
- Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infectionJournal of Reproductive Immunology, 2010
- Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infectionJournal of General Virology, 2009
- Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated samplingSexually Transmitted Infections, 2009
- Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivationJournal of Experimental Medicine, 2007
- Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapyArchives of Virology, 2005
- Quantitative Stability of DNA after Extended Storage of Clinical Specimens as Determined by Real-Time PCRJournal of Clinical Microbiology, 2002
- Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive PersonsNew England Journal of Medicine, 2000
- Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.Journal of Clinical Investigation, 1997
- Evaluation of Herpes Simplex Virus Vaccines in Animals: The Guinea Pig Vaginal ModelClinical Infectious Diseases, 1991